Schultes Birgit C

EVP, Chief Scientific Officer at NTLA

Sold, on record
$79k
Dollars the filings state
Form 4 sales
2
Latest Jan 5, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • NTLAIntellia Therapeutics, Inc.EVP, Chief Scientific Officer

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale NTLANo plan
    Oct 1, 2025 2025

    Sold 31 shares at $17.38 ($539)

    Schultes Birgit C, EVP, Chief Scientific Officer

    No 10b5-1 planSold 0% of holdings ($1.8M position)105,184 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale NTLANo plan
    Jan 5, 2026 +96 days

    Sold 8,508 shares at $9.21 ($78k)

    Schultes Birgit C, EVP, Chief Scientific Officer

    No 10b5-1 planSold 7.9% of holdings ($986k position)98,533 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Schultes Birgit C
Source
Jan 5, 2026Jan 7, 2026NTLAEVP, Chief Scientific OfficerForm 4 sale8,508$78k7.9%No planSEC
Oct 1, 2025Oct 3, 2025NTLAEVP, Chief Scientific OfficerForm 4 sale31$5390.0%No planSEC